BYSI · BeyondSpring Inc
United States · RS rating 10 · As of 2026-11-03
| Price | 0.62 USD |
|---|---|
| 1-day change | -22.9% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 20 / 16 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 10 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +73.6% |
| Market cap (USD) | $68.3M |